BioSense Solutions is a privately held company, located in Farum, 20km north of Copenhagen, Denmark. BioSense Solutions was established in May 2017 through a technology buy-out from Philips BioCell. The agreement includes all rights to sales, service, production, and development of the oCelloScope platform.
We are a team of engineers, physicists, microbiologists, and software developers all with a shared passion for imaging and microbiology. Today, the oCelloScope Live-Cell Imaging platform is used all over the world to help battle Antimicrobial Resistance (AMR). The technology is truly versatile and is also used by microbial research teams in – probiotics, co-culture studies, morphology, fungal spore development, preservatives testing, medium optimization, spike testing and more… Our philosophy is to develop with you and therefore most new software or hardware developments are based on oCelloScope user input.
May 2017, BioSense Solutions has taken over the oCelloScope Platform from Philips BioCell through buy out, including sales, service, production and development.
Unisensor launched the oCelloScope system in 2013, an analytical instrument that can be used for microbiological studies on a research application basis.
Unisensor was founded in 1997 By Tom Olesen and was privately held company with approx. 35 employees before it was acquired by Royal Philips in 2014 and Philips BioCell was formed. Over the years the company’s product line has included several OEM solutions in product development projects with international partners.